secwatch / observer
8-K filed June 29, 2023, 7:59 PM ET ticker BIIB CIK 0000875045
other confidence high sentiment neutral materiality 0.15

Biogen shareholders elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting

BIOGEN INC.

item 5.07item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Advisory vote on executive compensation at the 2023-06-26 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-26
Exact text from the filing
3. Stockholders approved the advisory vote on executive compensation, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 82,640,454 36,292,390 191,733 8,719,273
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Ratification of selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-26 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-26
Exact text from the filing
2. Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 123,393,644 4,311,034 139,172 —
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Election of Susan K. Langer to the Board of Directors for a one-year term at the 2023-06-26 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-26
Exact text from the filing
5. Stockholders elected Susan K. Langer to the Board of Directors to serve for a one-year term extending until the 2024 annual meeting of stockholders and her successor is duly elected and qualified, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 64,037,638 46,616,578 8,470,361 8,719,273
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Election of seven nominees to the Board of Directors for a one-year term at the 2023-06-26 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-26
Exact text from the filing
1. Stockholders elected seven nominees to the Board of Directors to serve for a one-year term extending until the 2024 annual meeting of stockholders and their successors are duly elected and qualified, with the votes cast as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Caroline Dorsa 91,426,287 27,419,853 278,437 8,719,273 Maria C. Freire 75,764,531 43,230,969 129,077 8,719,273 William A. Hawkins 73,182,735 45,804,008 137,834 8,719,273 Jesus B. Mantas 92,085,202 26,910,381 128,994 8,719,273 Eric K. Rowinsky 68,024,971 50,987,191 112,415 8,719,273 Stephen A. Sherwin 93,133,091 25,889,684 101,802 8,719,273 Christopher A. Viehbacher 116,996,008 2,026,614 101,955 8,719,273
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOGEN INC. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-06-26 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-06-26
Exact text from the filing
4. Stockholders approved, on an advisory basis, annually as the frequency of the advisory vote on executive compensation, with the votes cast as follows: 1 Year 2 Years 3 Years Abstentions 115,841,797 75,456 2,254,126 953,198
View on SEC.gov

Browse all shareholder votes →

BIOGEN INC. filing history →

Source: SEC EDGAR
accession 0000875045-23-000024
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.